| Blood Pressure and Hypertension Studies | Lifetime | 49 | DE 2 | 99.75 |
| Heart Rate Variability and Autonomic Control | Lifetime | 64 | DE 3 | 99.60 |
| Hormonal Regulation and Hypertension | Lifetime | 58 | DE 9 | 99.57 |
| Renal and Vascular Pathologies | Lifetime | 45 | DE 3 | 99.50 |
| Cardiovascular Health and Disease Prevention | Lifetime | 57 | DE 1 | 99.59 |
| Sodium Intake and Health | Lifetime | 25 | DE 2 | 99.34 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 54 | DE 2 | 99.14 |
| Renin-Angiotensin System Studies | Lifetime | 49 | DE 10 | 99.15 |
| Hemodynamic Monitoring and Therapy | Lifetime | 371 | DE 17 | 97.86 |
| Chronic Kidney Disease and Diabetes | Lifetime | 322 | DE 18 | 98.16 |
| Nitric Oxide and Endothelin Effects | Lifetime | 716 | DE 74 | 97.36 |
| Diabetes Treatment and Management | Lifetime | 804 | DE 48 | 97.26 |
| Dialysis and Renal Disease Management | Lifetime | 699 | DE 29 | 97.03 |
| Renal function and acid-base balance | Lifetime | 375 | DE 20 | 96.31 |
| Retinal Imaging and Analysis | Lifetime | 739 | DE 28 | 96.69 |
| Pharmacology and Obesity Treatment | Lifetime | 449 | DE 24 | 95.35 |
| Medication Adherence and Compliance | Lifetime | 541 | DE 16 | 93.33 |
| Heart rate and cardiovascular health | Lifetime | 123 | DE 9 | 91.76 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 22 | DE 2 | 99.51 |
| Sodium Intake and Health | 2021-2025 | 6 | DE 1 | 99.09 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 28 | DE 1 | 98.26 |
| Renal and Vascular Pathologies | 2021-2025 | 20 | DE 2 | 98.58 |
| Heart Rate Variability and Autonomic Control | 2021-2025 | 60 | DE 6 | 97.73 |
| Dialysis and Renal Disease Management | 2021-2025 | 341 | DE 9 | 93.94 |
| Hormonal Regulation and Hypertension | 2021-2025 | 216 | DE 24 | 92.57 |
| Diabetes Treatment and Management | 2021-2025 | 765 | DE 36 | 92.28 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 442 | DE 18 | 87.60 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 291 | DE 15 | 82.52 |
| Migraine and Headache Studies | 2021-2025 | 955 | DE 59 | 73.70 |
| Pharmaceutical Economics and Policy | 2021-2025 | 910 | DE 29 | 71.30 |
| Pharmacology and Obesity Treatment | 2021-2025 | 631 | DE 28 | 68.00 |
| Heart rate and cardiovascular health | 2021-2025 | 169 | DE 5 | 48.21 |
| Renal function and acid-base balance | 2021-2025 | 913 | DE 42 | 49.14 |
| Renin-Angiotensin System Studies | 2021-2025 | 872 | DE 66 | 28.67 |
| Pharmaceutical industry and healthcare | 2021-2025 | 745 | DE 8 | 20.52 |
